Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Bio-Path completes treatment of second cohort in BP-100-1.01 study

Feb. 8, 2012

Erivedge launched in U.S.

Feb. 8, 2012

Japanese authorities remove condition for approval of Tarceva in NSCLC

Feb. 8, 2012

New vaccines for human papillomavirus prepared in China

Feb. 8, 2012

Foretinib shows promise in large papillary renal cell carcinoma study

Feb. 8, 2012

RNA-loaded dendritic cell vaccine shows promise combined with sunitinib

Feb. 8, 2012

PharmaGap reports data on GAP-107B8 in models of ovarian cancer

Feb. 7, 2012

Novartis discloses new protein kinase inhibitors

Feb. 7, 2012

Wilex receives grant for PI3K inhibitor

Feb. 7, 2012

Molecular Insight Pharmaceuticals to evaluate targeted radiopharmaceutical for prostate cancer

Feb. 7, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 30, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Roche identifies new TREM2 agonists
BioWorld Science
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...
Plasticity, properly parsed, provides psychiatric platform
BioWorld
If Benjamin Braddock, of The Graduate fame, were a young neuroscientist in the 21st century instead of a liberal arts graduate in 1967, the advice he received...